Published on in Vol 23, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26957, first published .
Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis

Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis

Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis

Journals

  1. Worth C, Nutter P, Dunne M, Salomon-Estebanez M, Banerjee I, Harper S. HYPO-CHEAT’s aggregated weekly visualisations of risk reduce real world hypoglycaemia. DIGITAL HEALTH 2022;8:205520762211297 View
  2. Xie J, Zhong F, Guo Z, Li X, Wang J, Gao Z, Chang B, Yang J. Hyperinsulinemia impairs the metabolic switch to ketone body utilization in proximal renal tubular epithelial cells under energy crisis via the inhibition of the SIRT3/SMCT1 pathway. Frontiers in Endocrinology 2022;13 View
  3. Worth C, Tropeano Y, Gokul P, Cosgrove K, Salomon-Estebanez M, Senniappan S, Dastamani A, Banerjee I. Insight into hypoglycemia frequency in congenital hyperinsulinism: evaluation of a large UK CGM dataset. BMJ Open Diabetes Research & Care 2022;10(3):e002849 View
  4. Auckburally S, Worth C, Salomon-Estebanez M, Nicholson J, Harper S, Nutter P, Banerjee I. Families’ Experiences of Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A Thematic Analysis. Frontiers in Endocrinology 2022;13 View
  5. Worth C, Hoskyns L, Salomon-Estebanez M, Nutter P, Harper S, Derks T, Beardsall K, Banerjee I. Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023. Frontiers in Endocrinology 2023;14 View
  6. Worth C, Dunne M, Salomon-Estebanez M, Harper S, Nutter P, Dastamani A, Senniappan S, Banerjee I. The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism. Frontiers in Endocrinology 2022;13 View
  7. Ng S, Dearman S, Fisher M, Mushtaq T, Randell T. Paediatric Society and Hyperinsulinism Charity National Surveys on CGM Access for Patients With Recurrent Hypoglycaemia. Journal of the Endocrine Society 2023;7(4) View
  8. Worth C, Nutter P, Salomon-Estebanez M, Auckburally S, Dunne M, Banerjee I, Harper S. The behaviour change behind a successful pilot of hypoglycaemia reduction with HYPO-CHEAT. DIGITAL HEALTH 2023;9 View
  9. Thornton P, De Leon D, Empting S, Zangen D, Kendall D, Birch S, Bøge E, Ivkovic J, Banerjee I. Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children. The Journal of Clinical Endocrinology & Metabolism 2024;109(4):1071 View
  10. Gariepy M, Yoosefi N, Silva C, Chanoine J, Abdulhussein F. The use of CGM to identify hypoglycemia and glycemic patterns in congenital hyperinsulinism. Journal of Pediatric Endocrinology and Metabolism 2023;36(12):1133 View
  11. Worth C, Worthington S, Auckburally S, O’Shea E, Ahmad S, Fullwood C, Salomon-Estebanez M, Banerjee I. First Accuracy and User-Experience Evaluation of New Continuous Glucose Monitoring System for Hypoglycemia Due to Hyperinsulinism. Journal of Diabetes Science and Technology 2024 View
  12. Overduin R, Venema A, Lubout C, Fokkert-Wilts M, De Boer F, Schreuder A, Rossi A, Derks T. Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational study. Molecular Genetics and Metabolism 2024;143(1-2):108573 View